Teva Pharmaceuticals USA, Inc v. Bayer Pharma AG
IPR2022-01513 | Patent Trial and Appeal Board
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Filing Date | # | Filing and Exhibits |
---|---|---|
7/28/2023 | 07-28-2023-Board | Board Final Written Decision: original 11: Determining All Challenged Claims Unpatentable 35 U.S.C. § 318(a) |
10/19/2022 | 10-19-2022-Board | Board Institution Decision: Joined 10: Institution Decision: Joined |
10/6/2022 | 10-06-2022-Patent_Owner | Patent Owner Notice 9: Joint Notice of Stipulation Concerning Joinder |
10/5/2022 | 10-05-2022-Petitioner | Petitioner Exhibit List 8: Petitioner's Updated Exhibit List
|
9/30/2022 | 09-30-2022-Board | Board Notice: Notice filing date accorded 6: EXPUNGED |
9/21/2022 | 09-21-2022-Patent_Owner | Patent Owner Power of Attorney 4: Patent Owner Power of Attorney Patent Owner Mandatory Notice 5: Patent Owner Mandatory Notices |
9/9/2022 | 09-09-2022-Petitioner | Petitioner Power of Attorney 1: Petitioner's Power of Attorney Event:PetitionPetitioner Petition 2: Petition for Inter Partes Review Petitioner Motion 3: Petitioner's Motion for Joinder
|